Parse Biosciences and Integra Ink Pact For Automated Single Cell Workflows

Parse Biosciences, a main supplier of open and versatile single cell sequencing arrangements, reported it has gone into a concurrence with Integra Biosciences to coordinate the help In addition to with worked in Parse Evercode single cell conventions. By combining the semi-automated liquid handling of the Assist Plus with the scale of the Parse technology, the workflow's throughput and efficiency will be further enhanced.

As part of the agreement, Parse will sell a bundled solution composed of Evercode single cell reagents and an application-enabled Integra Assist Plus instrument directly to customers.

“The Integra Assist Plus will allow scientists to seamlessly profile many millions of cells per week and reduce hands-on time by as much as 80%,” said Charlie Roco, Parse co-founder and CTO. He added, “The first Parse products enabled on the Assist Plus will be Evercode Whole Transcriptome kits. We look forward to evolving this offering, building a growing library as applications and additional product support expand.”

The move supports Parse’s efforts to dramatically expand the single cell market by providing cost effective, instrument-agnostic, and accessible single cell sequencing solutions. The Assist Plus is an easy-to-use instrument, trusted worldwide by thousands of laboratories. As part of the deal, Parse customers will be supported by both the Parse Biosciences and Integra field service and sales teams, as per pharmabiz.

“Integra is excited to partner with Parse to provide the instrumentation, installation and training, and field service capabilities to enable Parse and Parse's customers with reliable and rapid pre-sales and post-sales support,” said Larry Keene, Integra SVP of strategic sales. He added, “The collaboration between the two organizations will bring great value to Parse's customers."

Parse Biosciences is a global provider of life sciences with the goal of accelerating advancements in scientific research and human health.